Dwivedi, Alok Kumar
Dubey, Pallavi
Cistola, David P.
Reddy, Sireesha Y.
Article History
First Online: 12 March 2020
Compliance with Ethical Standards
:
: Alok Kumar Dwivedi, Pallavi Dubey, and Sireesha Y. Reddy declare that they do not have any conflict of interest.David P. Cistola reports a grant from the US NIH/National Heart Lung and Blood Institute, R21 HL143030. In addition, Dr. Cistola has three broadly relevant patents and patent applications: (1) “Methods for Monitoring Changes in the Core of Lipoprotein Particles in Metabolism and Disease,” U.S. utility patent, issued January 24, 2017, as US patent number 9,551,768. Assignee: East Carolina University, Inventors: Cistola, David P.; Robinson, Michelle D; (2) “Methods and Tools for Diagnosing Insulin Resistance and Assessing Health Status Using NMR Relaxation Times for Water.” U.S. provisional patent 62/13,112. Filed February 6, 2015; PCT patent PCT/US2016/016906, filed February 6, 2016. Published, 8/11/2016; U.S. non-provisional patent 15/548,442, filed 8/3/2017, published 1/25/2018. Assignee: University of North Texas Health Science Center, Fort Worth Inventors: Cistola, David P.; Robinson, Michelle D., patent pending; and (3) “Method and System for Non-invasive Measurement of Metabolic Health.” U.S. non-provisional patent application no. 15/911,728, filed 3/5/2018; published 9/5/2019 as US 2019/0271749 A1. Assignee: Texas Tech University Inventors: Cistola, David P.; Patel, Vipulkumar, patent pending.
: This article does not contain any studies with human or animal subjects performed by any of the authors.